The National Medicines Authority (Infarmed) ordered the withdrawal from the market of a lot of the medication Salofalk, used in the treatment of intestinal inflammations. The recall decision was officially communicated to the competent entities.
The medication in question is produced by the company Dr. Falk Pharma Portugal, specialized in digestive and metabolic medicine. The pharmaceutical company will be responsible for carrying out the voluntary recall of the lot identified by the health authorities.
The measure aims to protect public health, ensuring that only medications that meet all quality and safety standards remain available for patients who need this treatment.
